Indication
Lung Disease
3 clinical trials
3 products
1 drug
Clinical trial
An Open-label, Single-arm, Multi-center, Phase 2 Study to Evaluate SHR-1210(Anti-PD-1 Antibody) in Patients With Advanced or Metastatic Non-Small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2020-08-20
Product
SHR-1210Clinical trial
Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19Status: Completed, Estimated PCD: 2023-12-31
Product
Longidaza®Drug
VarlilumabClinical trial
A Phase 1, Randomized, Double Blinded, Placebo Controlled, First-in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of RSN0402 in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2024-12-27
Product
RSN0402